Influx of Extended-Spectrum β-Lactamase—Producing Enterobacteriaceae into the Hospital

Background. The prevalence of infections caused by extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies. Methods. Isolates from 2 patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2006-04, Vol.42 (7), p.925-934
Hauptverfasser: Ben-Ami, R., Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Giladi, M., Chmelnitsky, I., Leavitt, A., Carmeli, Y.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 934
container_issue 7
container_start_page 925
container_title Clinical infectious diseases
container_volume 42
creator Ben-Ami, R.
Schwaber, M. J.
Navon-Venezia, S.
Schwartz, D.
Giladi, M.
Chmelnitsky, I.
Leavitt, A.
Carmeli, Y.
description Background. The prevalence of infections caused by extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies. Methods. Isolates from 2 patient cohorts—patients with gram-negative bacteremia within 2 days after admission and patients screened for fecal colonization at admission—were assessed for ESBL production. ESBL phenotype was confirmed according to Clinical and Laboratory Standards Institute guidelines. Predictors of ESBL phenotype were examined by univariate and multivariate analyses. Results. Of 80 Enterobacteriaceae isolates from blood samples obtained at admission to the hospital, 13.7% produced ESBL. Thirty-eight patients with ESBL-positive isolates and 72 with ESBL-negative isolates were included in a case-control study. Predictors of ESBL production were male sex and nursing home residence (area under receiver operator characteristic curve, 0.7). Of 241 persons screened at admission, 26 (10.8%) had fecal carriage of ESBL-producing Enterobacteriaceae. Predictors of fecal carriage were poor functional status, antibiotic use, chronic renal insufficiency, liver disease, and use of histamine2 blockers (area under receiver operator characteristic curve, 0.8). Four (15.4%) of the 26 individuals with fecal carriage had subsequent bacteremia with ceftazidime-resistant Enterobacteriaceae, compared with 1 (0.5%) noncarrier (odds ratio, 38.9; P < .001). Of 80 ESBL-producing Enterobacteriaceae isolates obtained at admission, 65 were health care associated, and 15 were community acquired. The 15 community-acquired ESBL-producing Enterobacteriaceae belonged to diverse clones. The most prevalent ESBL gene among these isolates was CTX-M-2 (found in 53.3% of the isolates). Conclusions. We report high rates of bacteremia and colonization with ESBL-producing Enterobacteriaceae at admission to our institution, which may undermine infection-control measures and complicate the selection of empirical treatment.
doi_str_mv 10.1086/500936
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67715661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4463748</jstor_id><oup_id>10.1086/500936</oup_id><sourcerecordid>4463748</sourcerecordid><originalsourceid>FETCH-LOGICAL-i325t-79853b769ee96fd6fb767e4e66cea149014cbef708ffd058a84792d053bf4fd83</originalsourceid><addsrcrecordid>eNqFkU1O3TAUha2qqPy0rKCq0gmzgP38m2GFXnmgpwdqqdQysZzkug0kcbAd6TFjEayEhXQRrASjUBh2dI90Ph3dew9CuwTvE6zEAce4oOIN2iKcylzwgrxNGnOVM0XVJtoO4RJjQhTm79AmEZwQydkW-nXc23ZcZ85m83WEvoY6_z5AFf3YZX_v86WpoulMgIfbuzPv6rFq-t_ZvI_gXZk88I2pwEDW9NFl8Q9kCxeGJpr2Pdqwpg3w4XnuoB9f5-eHi3x5enR8-GWZN3TGYy4LxWkpRQFQCFsLm7QEBkKkWMIKTFhVgpVYWVune4xispglRUvLbK3oDtqbcgfvrkcIUXdNqKBtTQ9uDFpISbgQ5L8gkUQRzngCPz2DY9lBrQffdMbf6H9fS8DnCXDj8Opi_dSEnppIzMeJuQzR-ReKMUEle9o6n-wmRFi_2MZfpYWp5Hrx80Kfr2Zn7OTbSq_oI6YYkeI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17181545</pqid></control><display><type>article</type><title>Influx of Extended-Spectrum β-Lactamase—Producing Enterobacteriaceae into the Hospital</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Ben-Ami, R. ; Schwaber, M. J. ; Navon-Venezia, S. ; Schwartz, D. ; Giladi, M. ; Chmelnitsky, I. ; Leavitt, A. ; Carmeli, Y.</creator><creatorcontrib>Ben-Ami, R. ; Schwaber, M. J. ; Navon-Venezia, S. ; Schwartz, D. ; Giladi, M. ; Chmelnitsky, I. ; Leavitt, A. ; Carmeli, Y.</creatorcontrib><description>Background. The prevalence of infections caused by extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies. Methods. Isolates from 2 patient cohorts—patients with gram-negative bacteremia within 2 days after admission and patients screened for fecal colonization at admission—were assessed for ESBL production. ESBL phenotype was confirmed according to Clinical and Laboratory Standards Institute guidelines. Predictors of ESBL phenotype were examined by univariate and multivariate analyses. Results. Of 80 Enterobacteriaceae isolates from blood samples obtained at admission to the hospital, 13.7% produced ESBL. Thirty-eight patients with ESBL-positive isolates and 72 with ESBL-negative isolates were included in a case-control study. Predictors of ESBL production were male sex and nursing home residence (area under receiver operator characteristic curve, 0.7). Of 241 persons screened at admission, 26 (10.8%) had fecal carriage of ESBL-producing Enterobacteriaceae. Predictors of fecal carriage were poor functional status, antibiotic use, chronic renal insufficiency, liver disease, and use of histamine2 blockers (area under receiver operator characteristic curve, 0.8). Four (15.4%) of the 26 individuals with fecal carriage had subsequent bacteremia with ceftazidime-resistant Enterobacteriaceae, compared with 1 (0.5%) noncarrier (odds ratio, 38.9; P &lt; .001). Of 80 ESBL-producing Enterobacteriaceae isolates obtained at admission, 65 were health care associated, and 15 were community acquired. The 15 community-acquired ESBL-producing Enterobacteriaceae belonged to diverse clones. The most prevalent ESBL gene among these isolates was CTX-M-2 (found in 53.3% of the isolates). Conclusions. We report high rates of bacteremia and colonization with ESBL-producing Enterobacteriaceae at admission to our institution, which may undermine infection-control measures and complicate the selection of empirical treatment.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/500936</identifier><identifier>PMID: 16511754</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Aged ; Aged, 80 and over ; Antibiotics ; Articles and Commentaries ; Bacteremia ; Bacteremia - microbiology ; Bacteria ; beta-Lactamases - biosynthesis ; Case-Control Studies ; Cross Infection - microbiology ; Electrophoresis, Gel, Pulsed-Field ; Enterobacteriaceae ; Enterobacteriaceae - drug effects ; Enterobacteriaceae - enzymology ; Enterobacteriaceae - isolation &amp; purification ; Escherichia coli ; Feces - microbiology ; Female ; Hospital admissions ; Humans ; Infections ; Klebsiella ; Klebsiella pneumoniae ; Male ; Microbial Sensitivity Tests ; Multivariate Analysis ; Phenotypes</subject><ispartof>Clinical infectious diseases, 2006-04, Vol.42 (7), p.925-934</ispartof><rights>Copyright 2006 The Infectious Diseases Society of America</rights><rights>2006 by the Infectious Diseases Society of America 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4463748$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4463748$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16511754$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ben-Ami, R.</creatorcontrib><creatorcontrib>Schwaber, M. J.</creatorcontrib><creatorcontrib>Navon-Venezia, S.</creatorcontrib><creatorcontrib>Schwartz, D.</creatorcontrib><creatorcontrib>Giladi, M.</creatorcontrib><creatorcontrib>Chmelnitsky, I.</creatorcontrib><creatorcontrib>Leavitt, A.</creatorcontrib><creatorcontrib>Carmeli, Y.</creatorcontrib><title>Influx of Extended-Spectrum β-Lactamase—Producing Enterobacteriaceae into the Hospital</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Background. The prevalence of infections caused by extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies. Methods. Isolates from 2 patient cohorts—patients with gram-negative bacteremia within 2 days after admission and patients screened for fecal colonization at admission—were assessed for ESBL production. ESBL phenotype was confirmed according to Clinical and Laboratory Standards Institute guidelines. Predictors of ESBL phenotype were examined by univariate and multivariate analyses. Results. Of 80 Enterobacteriaceae isolates from blood samples obtained at admission to the hospital, 13.7% produced ESBL. Thirty-eight patients with ESBL-positive isolates and 72 with ESBL-negative isolates were included in a case-control study. Predictors of ESBL production were male sex and nursing home residence (area under receiver operator characteristic curve, 0.7). Of 241 persons screened at admission, 26 (10.8%) had fecal carriage of ESBL-producing Enterobacteriaceae. Predictors of fecal carriage were poor functional status, antibiotic use, chronic renal insufficiency, liver disease, and use of histamine2 blockers (area under receiver operator characteristic curve, 0.8). Four (15.4%) of the 26 individuals with fecal carriage had subsequent bacteremia with ceftazidime-resistant Enterobacteriaceae, compared with 1 (0.5%) noncarrier (odds ratio, 38.9; P &lt; .001). Of 80 ESBL-producing Enterobacteriaceae isolates obtained at admission, 65 were health care associated, and 15 were community acquired. The 15 community-acquired ESBL-producing Enterobacteriaceae belonged to diverse clones. The most prevalent ESBL gene among these isolates was CTX-M-2 (found in 53.3% of the isolates). Conclusions. We report high rates of bacteremia and colonization with ESBL-producing Enterobacteriaceae at admission to our institution, which may undermine infection-control measures and complicate the selection of empirical treatment.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibiotics</subject><subject>Articles and Commentaries</subject><subject>Bacteremia</subject><subject>Bacteremia - microbiology</subject><subject>Bacteria</subject><subject>beta-Lactamases - biosynthesis</subject><subject>Case-Control Studies</subject><subject>Cross Infection - microbiology</subject><subject>Electrophoresis, Gel, Pulsed-Field</subject><subject>Enterobacteriaceae</subject><subject>Enterobacteriaceae - drug effects</subject><subject>Enterobacteriaceae - enzymology</subject><subject>Enterobacteriaceae - isolation &amp; purification</subject><subject>Escherichia coli</subject><subject>Feces - microbiology</subject><subject>Female</subject><subject>Hospital admissions</subject><subject>Humans</subject><subject>Infections</subject><subject>Klebsiella</subject><subject>Klebsiella pneumoniae</subject><subject>Male</subject><subject>Microbial Sensitivity Tests</subject><subject>Multivariate Analysis</subject><subject>Phenotypes</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1O3TAUha2qqPy0rKCq0gmzgP38m2GFXnmgpwdqqdQysZzkug0kcbAd6TFjEayEhXQRrASjUBh2dI90Ph3dew9CuwTvE6zEAce4oOIN2iKcylzwgrxNGnOVM0XVJtoO4RJjQhTm79AmEZwQydkW-nXc23ZcZ85m83WEvoY6_z5AFf3YZX_v86WpoulMgIfbuzPv6rFq-t_ZvI_gXZk88I2pwEDW9NFl8Q9kCxeGJpr2Pdqwpg3w4XnuoB9f5-eHi3x5enR8-GWZN3TGYy4LxWkpRQFQCFsLm7QEBkKkWMIKTFhVgpVYWVune4xispglRUvLbK3oDtqbcgfvrkcIUXdNqKBtTQ9uDFpISbgQ5L8gkUQRzngCPz2DY9lBrQffdMbf6H9fS8DnCXDj8Opi_dSEnppIzMeJuQzR-ReKMUEle9o6n-wmRFi_2MZfpYWp5Hrx80Kfr2Zn7OTbSq_oI6YYkeI</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>Ben-Ami, R.</creator><creator>Schwaber, M. J.</creator><creator>Navon-Venezia, S.</creator><creator>Schwartz, D.</creator><creator>Giladi, M.</creator><creator>Chmelnitsky, I.</creator><creator>Leavitt, A.</creator><creator>Carmeli, Y.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>20060401</creationdate><title>Influx of Extended-Spectrum β-Lactamase—Producing Enterobacteriaceae into the Hospital</title><author>Ben-Ami, R. ; Schwaber, M. J. ; Navon-Venezia, S. ; Schwartz, D. ; Giladi, M. ; Chmelnitsky, I. ; Leavitt, A. ; Carmeli, Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i325t-79853b769ee96fd6fb767e4e66cea149014cbef708ffd058a84792d053bf4fd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibiotics</topic><topic>Articles and Commentaries</topic><topic>Bacteremia</topic><topic>Bacteremia - microbiology</topic><topic>Bacteria</topic><topic>beta-Lactamases - biosynthesis</topic><topic>Case-Control Studies</topic><topic>Cross Infection - microbiology</topic><topic>Electrophoresis, Gel, Pulsed-Field</topic><topic>Enterobacteriaceae</topic><topic>Enterobacteriaceae - drug effects</topic><topic>Enterobacteriaceae - enzymology</topic><topic>Enterobacteriaceae - isolation &amp; purification</topic><topic>Escherichia coli</topic><topic>Feces - microbiology</topic><topic>Female</topic><topic>Hospital admissions</topic><topic>Humans</topic><topic>Infections</topic><topic>Klebsiella</topic><topic>Klebsiella pneumoniae</topic><topic>Male</topic><topic>Microbial Sensitivity Tests</topic><topic>Multivariate Analysis</topic><topic>Phenotypes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ben-Ami, R.</creatorcontrib><creatorcontrib>Schwaber, M. J.</creatorcontrib><creatorcontrib>Navon-Venezia, S.</creatorcontrib><creatorcontrib>Schwartz, D.</creatorcontrib><creatorcontrib>Giladi, M.</creatorcontrib><creatorcontrib>Chmelnitsky, I.</creatorcontrib><creatorcontrib>Leavitt, A.</creatorcontrib><creatorcontrib>Carmeli, Y.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ben-Ami, R.</au><au>Schwaber, M. J.</au><au>Navon-Venezia, S.</au><au>Schwartz, D.</au><au>Giladi, M.</au><au>Chmelnitsky, I.</au><au>Leavitt, A.</au><au>Carmeli, Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influx of Extended-Spectrum β-Lactamase—Producing Enterobacteriaceae into the Hospital</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2006-04-01</date><risdate>2006</risdate><volume>42</volume><issue>7</issue><spage>925</spage><epage>934</epage><pages>925-934</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Background. The prevalence of infections caused by extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies. Methods. Isolates from 2 patient cohorts—patients with gram-negative bacteremia within 2 days after admission and patients screened for fecal colonization at admission—were assessed for ESBL production. ESBL phenotype was confirmed according to Clinical and Laboratory Standards Institute guidelines. Predictors of ESBL phenotype were examined by univariate and multivariate analyses. Results. Of 80 Enterobacteriaceae isolates from blood samples obtained at admission to the hospital, 13.7% produced ESBL. Thirty-eight patients with ESBL-positive isolates and 72 with ESBL-negative isolates were included in a case-control study. Predictors of ESBL production were male sex and nursing home residence (area under receiver operator characteristic curve, 0.7). Of 241 persons screened at admission, 26 (10.8%) had fecal carriage of ESBL-producing Enterobacteriaceae. Predictors of fecal carriage were poor functional status, antibiotic use, chronic renal insufficiency, liver disease, and use of histamine2 blockers (area under receiver operator characteristic curve, 0.8). Four (15.4%) of the 26 individuals with fecal carriage had subsequent bacteremia with ceftazidime-resistant Enterobacteriaceae, compared with 1 (0.5%) noncarrier (odds ratio, 38.9; P &lt; .001). Of 80 ESBL-producing Enterobacteriaceae isolates obtained at admission, 65 were health care associated, and 15 were community acquired. The 15 community-acquired ESBL-producing Enterobacteriaceae belonged to diverse clones. The most prevalent ESBL gene among these isolates was CTX-M-2 (found in 53.3% of the isolates). Conclusions. We report high rates of bacteremia and colonization with ESBL-producing Enterobacteriaceae at admission to our institution, which may undermine infection-control measures and complicate the selection of empirical treatment.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>16511754</pmid><doi>10.1086/500936</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1058-4838
ispartof Clinical infectious diseases, 2006-04, Vol.42 (7), p.925-934
issn 1058-4838
1537-6591
language eng
recordid cdi_proquest_miscellaneous_67715661
source Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Aged
Aged, 80 and over
Antibiotics
Articles and Commentaries
Bacteremia
Bacteremia - microbiology
Bacteria
beta-Lactamases - biosynthesis
Case-Control Studies
Cross Infection - microbiology
Electrophoresis, Gel, Pulsed-Field
Enterobacteriaceae
Enterobacteriaceae - drug effects
Enterobacteriaceae - enzymology
Enterobacteriaceae - isolation & purification
Escherichia coli
Feces - microbiology
Female
Hospital admissions
Humans
Infections
Klebsiella
Klebsiella pneumoniae
Male
Microbial Sensitivity Tests
Multivariate Analysis
Phenotypes
title Influx of Extended-Spectrum β-Lactamase—Producing Enterobacteriaceae into the Hospital
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T06%3A22%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influx%20of%20Extended-Spectrum%20%CE%B2-Lactamase%E2%80%94Producing%20Enterobacteriaceae%20into%20the%20Hospital&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Ben-Ami,%20R.&rft.date=2006-04-01&rft.volume=42&rft.issue=7&rft.spage=925&rft.epage=934&rft.pages=925-934&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1086/500936&rft_dat=%3Cjstor_proqu%3E4463748%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17181545&rft_id=info:pmid/16511754&rft_jstor_id=4463748&rft_oup_id=10.1086/500936&rfr_iscdi=true